Marc Lustig

Marc Lustig

Amministratore Delegato presso PHARMACIELO LTD.

Patrimonio netto: 2 M $ in data 31/05/2026

53 anni
Finance
Process Industries
Health Technology

Profilo

Marc Lustig was the founder of CannaRoyalty Corp., founded in 2015, serving as Executive Chairman & Chief Executive Officer from 2018 to 2020.
Mr. Lustig was the founder of Trichome Financial Corp., founded in 2017, serving as Chairman from 2017 to 2021.
Mr. Lustig is the founder of Cannabis Royalties & Holdings Corp., founded in 2015, serving as Chief Executive Officer & Director from 2015 to 2020.
Mr. Lustig is also the founder of Cedars Cancer Foundation.
Mr. Lustig is Chairman & Chief Executive Officer at PharmaCielo Ltd. since 2023.
Mr. Lustig is Director at Cresco Labs LLC.
Mr. Lustig is Independent Director at Aequus Pharmaceuticals, Inc. since 2021.
Mr. Lustig is Director at Resolve Digital Health, Inc. Mr. Lustig is Director at L5 Capital, Inc. Mr. Lustig is Director at Cresco Labs, Inc. (Arizona) since 2021.
Mr. Lustig is Director at Cresco Labs, Inc. since 2020.
Mr. Lustig was Chairman at META Growth Corp.
from 2018 to 2020.
Mr. Lustig was Chairman at Trichome Financial Corp.
Mr. Lustig was Chairman at Wellfield Technologies, Inc. from 2021 to 2023.
Mr. Lustig was Executive Chairman at IM Cannabis Corp.
from 2019 to 2024.
Mr. Lustig was Director at RF Capital Group, Inc. Mr. Lustig was Independent Director at 22 Capital Corp.
Mr. Lustig was Independent Director at Planet 13 Holdings, Inc. from 2018 to 2019.
Mr. Lustig was Independent Director at BriaCell Therapeutics Corp.
from 2021 to 2024.
Mr. Lustig was Head-Capital Markets at Merck & Co., Inc. Mr. Lustig was Principal at Griffiths McBurney Corp.
Mr. Lustig was Head-Capital Markets at Dundee Capital Markets, Inc. from 2012 to 2014.
Mr. Lustig was Sales Associate at GMP Securities LP.
Mr. Lustig was Vice President at Orion Securities, Inc. Mr. Lustig was Principal at KES 7 Capital, Inc. Mr. Lustig completed graduate and MBAistration degrees at McGill University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
16/03/2026 24.262.580 ( 12,91% ) 2 M $ 31/05/2026
23/02/2026 192.232 ( 0,06% ) 176 277 $ 31/05/2026
21/04/2025 10.198.958 ( 4,92% ) 71 393 $ 31/05/2026
10/12/2024 17.403 ( 0,24% ) 63 347 $ 31/05/2026
24/09/2025 6.916.666 ( 5,21% ) 6 917 $ 31/05/2026
01/08/2025 1.589 ( 99,94% ) 1 457 $ 31/05/2026

Posizioni attive di Marc Lustig

SocietàPosizioneInizio
PHARMACIELO LTD. Amministratore Delegato 10/07/2023
CRESCO LABS INC. Direttore/Membro del Consiglio 29/07/2020
AEQUUS PHARMACEUTICALS INC. Direttore/Membro del Consiglio 15/02/2021
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -

Precedenti posizioni note di Marc Lustig

SocietàPosizioneFine
BRIACELL THERAPEUTICS CORP. Direttore/Membro del Consiglio 23/11/2024
NAVASOTA RESOURCES INC Presidente 05/06/2024
WELLFIELD TECHNOLOGIES INC. Presidente 06/10/2023
░░░░░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Marc Lustig

Formazione di Marc Lustig

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

19

Relazioni di 1° grado

25

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private25

Health Technology

Process Industries

Finance

Finance

Process Industries

Health Technology

Finance

Finance

Consumer Services

Finance

Finance

Health Technology

Process Industries

Process Industries

Health Technology

Finance

Retail Trade

Process Industries

Finance

Process Industries

Process Industries

Cedars Cancer Foundation

Finance

Finance

Finance

  1. Mercati
  2. Insiders
  3. Marc Lustig
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA